STAT@ASCO: Science vs. Cancer

About

The annual meeting of the American Society of Clinical Oncology is the leading showcase for oncology’s biggest breakthroughs and the latest cancer drug data. Join industry leaders, scientific experts, and STAT reporters for a deep look at the frontiers of cancer care and research, plus a preview of the meeting’s news. Drinks and light bites will be served. Follow along here for all STAT@ASCO 2026 events and live coverage.

The listed time reflects your local time; this event runs 6–9 p.m. CT.

Register now

Agenda

6:00-6:40 p.m. CT – Arrival & Networking Reception

Drinks and light bites will be served.

6:40-6:50 p.m. CT – Welcome from STAT

• Rick Berke, co-founder and executive editor, STAT
• Matthew Herper, senior writer, medicine; editorial director of events, STAT

6:50 p.m.-7:20 p.m. CT – Session to be Announced

Speakers to be announced

7:20 – 7:30 p.m. CT – Sponsor Session

• Dan Malarek, chief executive officer, Foundation Medicine (sponsor speaker)
• Matthew Herper, senior writer, medicine; editorial director of events, STAT

7:30 – 7:55 p.m. CT – Staying on Target

Revolution Medicines’ treatment for pancreatic cancer is one of the most exciting cancer medicines in years. Next up: the hard part. Hear how the pioneering company plans to turn its scientific breakthrough into a cornerstone treatment.

• Mark A. Goldsmith, M.D., Ph.D., president, chief executive officer and board chairman, Revolution Medicines
• Adam Feuerstein, senior writer, biotech, STAT (moderator)

7:55 – 8:05 p.m. CT – Sponsor Session

• Dietmar Berger, M.D., Ph.D., chief medical officer, Gilead Sciences (sponsor speaker)
• Rick Berke, co-founder and executive editor, STAT (moderator)

8:05 – 8:30 p.m. CT – Pazdur Unleashed

The former head of the FDA’s Oncology Center of Excellence has always had opinions. Now he can actually say them in public. Find out what’s on his mind and discuss the latest in cancer research – and watch him put STAT reporters on the spot.

• Richard Pazdur, M.D., former director, Oncology Center of Excellence; former director, Center for Drug Evaluation and Research, United States Food and Drug Administration
• Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

8:30 – 8:35 p.m. CT – Closing from STAT

• Katherine MacPhail, reporter, live journalism, STAT

8:35 – 9:00 p.m. CT – Networking Reception

Drinks and light bites will be served.